Menu
Back to User profile » Professor Stig Larsen
Papers published by Professor Stig Larsen:
Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
Butthongkomvong K, Raunroadroong N, Sorrarichingchai S, Sangsaikae I, Srimuninnimit V, Harling H, Larsen S
Breast Cancer: Targets and Therapy 2019, 11:43-51
Published Date: 14 January 2019
Randomized response surface pathway design with odd response outcomes in a Latin Square designed study
Holand T, Ellingsen K, Dewi S, Larsen S
Open Access Journal of Clinical Trials 2017, 9:75-84
Published Date: 14 September 2017
Development of a randomized two-dimensional response surface pathway design with two interventional and one response variables
Holand T, Dewi S, Larsen S
Open Access Journal of Clinical Trials 2016, 8:33-42
Published Date: 13 October 2016
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S
Breast Cancer: Targets and Therapy 2015, 7:163-164
Published Date: 29 June 2015
Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance
Lindkær-Jensen S, Larsen S, Habib-Lindkær-Jensen N, Fagertun HE
Drug Design, Development and Therapy 2015, 9:1481-1490
Published Date: 13 March 2015
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S
Breast Cancer: Targets and Therapy 2014, 6:179-189
Published Date: 27 November 2014